Morgan Stanley analyst Drew Ranieri downgrades Haemonetics (NYSE:HAE) from Overweight to Equal-Weight and lowers the price target from $147 to $83.
SS&C Technologies Hldgs Q1 Adj. EPS $1.25, Inline, Sales $1.30B Beat $1.29B Estimate
SS&C Technologies Hldgs (NASDAQ:SSNC) reported quarterly earnings of $1.25 per share which met the analyst consensus estimate. This is a 5.93 percent increase over earnings of $1.18 per share from the same period last
